2008
DOI: 10.1080/09513590802296245
|View full text |Cite
|
Sign up to set email alerts
|

Prevention of postmenopausal osteoporosis and associated fractures: Clinical evaluation of the choice between estrogen and bisphosphonates

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
14
0

Year Published

2011
2011
2015
2015

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 16 publications
(14 citation statements)
references
References 132 publications
0
14
0
Order By: Relevance
“…However, as shown in Figure 11, fracture risk does continue to increase with age [20]. Other side effects corresponding to estrogen use include possible mastalgia, headaches, and dyspepsia [25].…”
Section: Osteoporosis Treatment Optionsmentioning
confidence: 99%
See 1 more Smart Citation
“…However, as shown in Figure 11, fracture risk does continue to increase with age [20]. Other side effects corresponding to estrogen use include possible mastalgia, headaches, and dyspepsia [25].…”
Section: Osteoporosis Treatment Optionsmentioning
confidence: 99%
“…They have been shown to have long term effects after termination of treatment due to their potential sequestering by hydroxyapatite crystals. The release of the stored bisphosphonates occurs during the remodeling process inhibiting osteoclast function [25]. Bisphosphonates have been shown to inhibit the melavonic acid pathway which is critical for osteoclast function [26].…”
Section: Osteoporosis Treatment Optionsmentioning
confidence: 99%
“…But when that is not enough, there are two of main treatment options for osteoporosis which include increasing estrogen levels or delivering of bisphosphonates. Although both show decreased loss of BMD [8], estrogen has bad side effects for the patient [9] and bisphosphonates alter osteoclasts function negatively [10]. There has been some research done to show a positive effect combining both treatment options, but further research is needed [10].…”
Section: Treatment Options Of Osteoporosismentioning
confidence: 99%
“…Bisphosphonates work by suppressing bone resorption, or inhibiting osteoclasts [9]. They have shown to reduce vertebral and non-vertebral fractures so they are normally one of the first options in treating osteoporosis, especially in men where estrogen therapy is not an option [3].…”
Section: Treatment Options Of Osteoporosismentioning
confidence: 99%
See 1 more Smart Citation